Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(8%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_1
10
83%
Ph phase_2
2
17%

Phase Distribution

10

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
10(83.3%)
Phase 2Efficacy & side effects
2(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(11)

Detailed Status

Completed11
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 110 (83.3%)
Phase 22 (16.7%)

Trials by Status

completed1192%
recruiting18%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT05202353Phase 1

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Recruiting
NCT06352411Phase 1

A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

Completed
NCT06200467Phase 1

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Completed
NCT05896384Phase 1

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

Completed
NCT06352424Phase 1

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Completed
NCT05751226Phase 1

A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906

Completed
NCT05296733Phase 1

A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

Completed
NCT04667377Phase 2

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Completed
NCT04153929Phase 2

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Completed
NCT03591718Phase 1

A Study to Test Different Doses of BI 456906 in Patients With Obesity

Completed
NCT04384081Phase 1

A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2

Completed
NCT03175211Phase 1

Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12